TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
INSM

Insmed Inc

Healthcare · Biotechnology

121.00$ +0.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow INSM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+84.7% +23.0% +19.0% +66.4% +111.0% +39.0% +0.2% -27.2% +2.4% +4.1% +49.4%
+37.6% +15.7% +0.2% +45.2% +2.8% +34.1% +27.3% +25.3% +29.6% +29.5% +57.7%
+37.5% +15.7% +0.2% +57.4% -5.2% +34.1% +96.5% -34.9%
-134.0% +30.6% +39.5% -500.2% -696.5%
-35.5% +21.6% -28.5% +393.6% +185.3% -83.9% +6.8% +35.5% +34.5% +65.0% +48.5%
-35.3% +21.6% -28.5% +393.6% +185.3% -83.9% +842.3% -46.2% +546.6% +160.8% -88.9%
+106.6% -99.5% +35,055.8% -97.7% +3,085.2% -3.1% +7.3% +6.8%
-105.3% +1,235.0% -4.3% -100.2% +0.0% +3.3% -100.4% -103.3%
+97.9% -86.5% +1,142.4% +1.5% -26.2% -5.0% +126.0% +29.5% -78.8% +696.1% -28.9%
+172.8% -197.3% -47.9% -106.7% +306.0% +94.1% -265.6% -161.4%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?